Related Experiment Video
Updated: May 24, 2026

14:56
Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies
Published on: May 6, 2022
Systems biology-driven analysis of obesity-associated genes with transcript mapping and post-translational
Sudeepti Kulshrestha1, Priyanka Narad2
1Informatics and Data Centre, Indian Council of Medical Research (ICMR) Headquarters, New Delhi, India.
Biochemical and Biophysical Research Communications
|May 22, 2026
Summary
Genetic mutations in morbid obesity impact protein pathways through post-translational modification alterations. Identifying these key protein hubs offers new precision medicine targets for obesity treatment.
Area of Science:
- Genetics
- Molecular Biology
- Bioinformatics
Background:
- Morbid obesity is influenced by genetic variations, but their protein-level functional consequences, especially post-translational modifications (PTMs), are not well understood.
- Genome-wide association studies have identified numerous obesity-related genetic loci, yet the role of PTMs and their interactions remains unclear.
Purpose of the Study:
- To investigate the functional impact of genetic variations on proteins involved in morbid obesity.
- To explore the role of post-translational modifications (PTMs) in obesity-related genetic pathways.
- To identify key regulatory protein hubs and potential therapeutic targets.
Main Methods:
- Computationally identified gene candidates and single nucleotide polymorphisms (SNPs) from dbSNP.
- Mapped mutations using SnpEff and correlated gene/transcript IDs with UniProtKB accessions.
- Integrated PTM data from multiple databases and constructed a protein-PTM-disease interaction network in Cytoscape.
Main Results:
- Retrieved 66 obesity-related genes with 3581 mutations, noting excess missense and frameshift variants in key genes like LEPR and MC4R.
- Identified ALMS1, POMC, and LEPR as major topological hubs in the interaction network.
- Network analysis revealed PTM hotspots (phosphoserine, N-glycosylation) where mutations converge, potentially disrupting receptor signaling and contributing to obesity.
Conclusions:
- Linked genetic mutations in morbid obesity to protein regulatory pathways affected by PTM alterations.
- Identified specific topological bottlenecks with high centrality as targets for precision medicine initiatives in obesity.
Related Concept Videos
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
